# Guideline Freshness Report

**Run date:** 2026-02-14

## Summary

| Metric | Count |
|--------|-------|
| Total checked | 105 |
| Current | 100 |
| Newer version available | 2 |
| Health issues (retracted/erratum) | 0 |
| PMID not found | 0 |
| Skipped (no org/topic match) | 3 |

## âš  Items Requiring Review

### ðŸ”„ AAN Peripheral Neuropathy 2009
- **Type:** guideline
- **Current PMID:** 19056666
- **Citation:** England et al. Neurology 2009
- **Year:** 2009
- **Status:** newer_available
- **Newer candidate:** PMID 21497321 (2011)
  - Title: Evidence-based guideline: Treatment of painful diabetic neuropathy: report of the American Academy of Neurology, the American Association of Neuromuscular and Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation.
  - Journal: PM R
  - PubMed: https://pubmed.ncbi.nlm.nih.gov/21497321/

### ðŸ”„ AAN Brain Death 2010
- **Type:** guideline
- **Current PMID:** 20530327
- **Citation:** Wijdicks et al. Neurology 2010
- **Year:** 2010
- **Status:** newer_available
- **Newer candidate:** PMID 25565594 (2015)
  - Title: Update of clinical practice guidelines for brain death determination in an academic heath center.
  - Journal: J Neurosci Nurs
  - PubMed: https://pubmed.ncbi.nlm.nih.gov/25565594/


## Current (103 entries)

| Name | Type | PMID | Year |
|------|------|------|------|
| AAN ALS Practice Parameter 2009 | guideline | 19822873 | 2009 |
| AAN Bell's Palsy Guidelines 2012 | guideline | 23136264 | 2012 |
| AAN Concussion Guideline 2013 | guideline | 23508730 | 2013 |
| AAN Dystonia Guideline 2008 | guideline | 18458229 | 2008 |
| AAN Essential Tremor Guidelines 2011 | guideline | 22013182 | 2011 |
| AAN MCI Practice Parameter 2018 | guideline | 29282327 | 2018 |
| AAN MS Practice Guideline 2018 | guideline | 29686116 | 2018 |
| AAN Myotonic Dystrophy 2018 | guideline | 29592893 | 2018 |
| AAN Neuroprognostication Update 2023 | guideline | 36697245 | 2023 |
| AAN Practice Parameter GBS | guideline | 14504313 | 2003 |
| AAN SUDEP Guideline 2017 | guideline | 28438841 | 2017 |
| AAN Tics/Tourette 2019 | guideline | 31061208 | 2019 |
| AAN/AES First Seizure Guideline 2015 | guideline | 25901057 | 2015 |
| AAN/AES/SMFM Epilepsy & Pregnancy 2024 | guideline | 38748979 | 2024 |
| AAN/AHA/NCS Brain Death 2023 | guideline | 37829552 | 2023 |
| AAN/AHS Migraine Prevention 2012 | guideline | 22529202 | 2012 |
| AAN/EFNS Trigeminal Neuralgia 2008 | guideline | 18716236 | 2008 |
| AANEM Radiculopathy 2010 | guideline | 20645032 | 2010 |
| AAOS/ASSH Carpal Tunnel 2025 | guideline | 39637428 | 2025 |
| AASLD Wilson Disease 2008 | guideline | 18506894 | 2008 |
| ACOG Eclampsia 2020 | guideline | 32443079 | 2020 |
| ADAPT | trial | 34146511 | 2021 |
| AES Status Epilepticus 2016 | guideline | 26900382 | 2016 |
| AHA Endocarditis Guidelines 2015 | guideline | 26373316 | 2015 |
| AHA/ASA 2016 Rehab Guidelines | guideline | 27145936 | 2016 |
| AHA/ASA 2021 Secondary Prevention Guidelines | guideline | 34024117 | 2021 |
| AHA/ASA 2022 ICH Guidelines | guideline | 35579034 | 2022 |
| AHA/ASA 2023 SAH Guidelines | guideline | 37212182 | 2023 |
| AHA/ASA 2026 AIS Guidelines | guideline | 41582814 | 2026 |
| AHA/ASA CVT Guidelines 2011 | guideline | 21293023 | 2011 |
| ANNEXA-4 | trial | 30730782 | 2019 |
| APOLLO | trial | 29972753 | 2018 |
| ARISTOTLE | trial | 21870978 | 2011 |
| ASAM Alcohol Withdrawal 2020 | guideline | 31916890 | 2020 |
| ATACH-2 | trial | 27276234 | 2016 |
| ATTR-ACT | trial | 30145929 | 2018 |
| AVERT | trial | 25892679 | 2015 |
| Alzheimer's Association DETeCD-ADRD 2024 | guideline | 39713957 | 2024 |
| CADISS | trial | 25684164 | 2015 |
| CDC STI Treatment Guidelines 2021 | guideline | 34292926 | 2021 |
| CHANCE | trial | 23803136 | 2013 |
| CLOSE | trial | 28902593 | 2017 |
| CRYSTAL-AF | trial | 25259387 | 2014 |
| DAWN | trial | 29129157 | 2018 |
| DCCT | trial | 8366922 | 1993 |
| DECIMAL | trial | 17690311 | 2007 |
| DEFUSE-3 | trial | 29364767 | 2018 |
| DESTINY | trial | 17690310 | 2007 |
| EASL Wilson Disease 2012 | guideline | 22340672 | 2012 |
| ECST | trial | 9593407 | 1998 |
| EFNS Dystonia Guideline 2011 | guideline | 20482602 | 2011 |
| EFNS/PNS CIDP Guideline 2021 | guideline | 34327760 | 2021 |
| EFNS/PNS MMN Guideline 2010 | guideline | 21199100 | 2010 |
| EMBRACE | trial | 24963566 | 2014 |
| ENGAGE AF | trial | 24251359 | 2013 |
| ENRICH | trial | 38598795 | 2024 |
| ESCAPE | trial | 25671798 | 2015 |
| ESETT | trial | 31774955 | 2019 |
| ESO CVT Guidelines 2017 | guideline | 28833980 | 2017 |
| EXPAND | trial | 29576505 | 2018 |
| EXTEND-IA TNK | trial | 29694815 | 2018 |
| HAMLET | trial | 19269254 | 2009 |
| IDSA Aspergillosis 2016 | guideline | 27365388 | 2016 |
| IDSA Bacterial Meningitis Guidelines | guideline | 15494903 | 2004 |
| IDSA Coccidioidomycosis 2016 | guideline | 27470238 | 2016 |
| IDSA Encephalitis Guidelines 2008 | guideline | 18582201 | 2008 |
| IDSA Lyme Disease 2021 | guideline | 33417672 | 2021 |
| IDSA Neurocysticercosis 2018 | guideline | 29481580 | 2018 |
| IIHTT | trial | 24756514 | 2014 |
| INCH | trial | 27302126 | 2016 |
| INTERACT2 | trial | 23713578 | 2013 |
| ISAT | trial | 12414200 | 2002 |
| ISSUE-3 | trial | 22565936 | 2012 |
| MAGNIMS/CMSC MS Diagnosis 2021 | guideline | 34139157 | 2021 |
| MGTX | trial | 27509100 | 2016 |
| MISTIE III | trial | 30739747 | 2019 |
| MR CLEAN | trial | 25517348 | 2015 |
| NASCET | trial | 1852179 | 1991 |
| NASS Lumbar Stenosis 2013 | guideline | 23830297 | 2013 |
| NCS Status Epilepticus 2012 | guideline | 22528274 | 2012 |
| NEURO-TTR | trial | 29972757 | 2018 |
| NOA-08 | trial | 22578793 | 2012 |
| ONTT | trial | 1734247 | 1992 |
| ORATORIO | trial | 28002688 | 2017 |
| PATCH | trial | 27178479 | 2016 |
| POINT | trial | 29766750 | 2018 |
| PROGRESS | trial | 11589932 | 2001 |
| RE-LY | trial | 19717844 | 2009 |
| RE-VERSE AD | trial | 28693366 | 2017 |
| REDUCE | trial | 28902580 | 2017 |
| REGAIN | trial | 29066163 | 2017 |
| RESPECT | trial | 28902590 | 2017 |
| REVASCAT | trial | 25882510 | 2015 |
| ROCKET-AF | trial | 21830957 | 2011 |
| SPARCL | trial | 16899775 | 2006 |
| SPS3 | trial | 23726159 | 2013 |
| STICH | trial | 15680453 | 2005 |
| STICH II | trial | 23726393 | 2013 |
| SWIFT-PRIME | trial | 26352820 | 2015 |
| THALES | trial | 32668111 | 2020 |
| TICH-2 | trial | 29778325 | 2018 |
| TTM | trial | 24237006 | 2013 |
| WHO TB Guidelines 2022 | guideline | 35536703 | 2022 |